Researchers just announced they have found clear differences in the blood of Long COVID patients—this is the scientific proof that some in the health care sector want to see. Right before this news broke, we asked Dr. Lisa Sanders, the director of the new Yale New Haven Long COVID Multidisciplinary Care Center, about the lack of a Long COVID blood test.
She pushed back on skeptics because she has seen clinical evidence of the condition. Now, it appears Dr. Sanders and her colleagues will indeed be able to confirm Long COVID is a biological illness.
Dr. Sanders, who also writes The New York Times Diagnosis column, explained her patients are getting better through a variety of approaches and she’s hopeful the caseload will continue to decrease.
Join hosts Mark Masselli and Margaret Flinter for this important conversation that’s part of our continuing coverage of Long COVID.
Conversations on Health Care features in-depth discussions on health policy and innovation with industry newsmakers from around the globe. https://www.chcradio.com
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
The new Rural Health Transformation Program aims to improve “healthcare access, quality, and outcomes” with…
New research. New technology. New possibilities. On this special 2025 Rewind and Look Ahead episode…
Health care policy faced major upheavals during the past 12 months and the effects are…
Eighty percent of maternal deaths in the United States are considered preventable. So why do…
Originally broadcast December 11, 2025 Congress is scrambling to find a solution to the enhanced…
Originally broadcast December 4, 2025 The doctor who once led the Centers for Disease Control…